Prosecution Insights
Last updated: August 17, 2026

Examiner: HOFFPAUIR, ANDREW ELI

Tech Center 3700 • Art Units: 3774 3791

This examiner grants 42% of resolved cases

Performance Statistics

41.8%
Allow Rate
-28.2% vs TC avg
143
Total Applications
+50.4%
Interview Lift
1420
Avg Prosecution Days
Based on 91 resolved cases, 2023–2026

Rejection Statute Breakdown

19.6%
§101 Eligibility
8.1%
§102 Novelty
45.1%
§103 Obviousness
26.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18521617 METHOD AND APPARATUS FOR USING AN EXPANDABLE ELEMENT TO ASCERTAIN VESSEL DIAMETER Non-Final OA Boston Scientific Scimed, Inc.
18767471 POLARIZED PHOTOPLETHYSMOGRAPHY (PPG) WITH IMPROVED PERFUSION SIGNAL FOR ADVANCED BIOSENSING Non-Final OA Samsung Electronics Co., Ltd.
18303265 METHOD AND ELECTRONIC DEVICE FOR DETERMINING SKIN INFORMATION USING HYPER SPECTRAL RECONSTRUCTION Non-Final OA SAMSUNG ELECTRONICS CO., LTD.
18686047 INFORMATION PROCESSING APPARATUS, METHOD AND COMPUTER PROGRAM PRODUCT FOR MEASURING A LEVEL OF COGNITIVE DECLINE IN A USER Final Rejection Sony Group Corporation
17854036 PATIENT SUPPORT APPARATUS WITH SPECTROMETER Non-Final OA Stryker Corporation
18044660 Respiratory Feedback For Improved Exercise Performance Non-Final OA QUALCOMM Incorporated
17964271 TECHNIQUES FOR MEASURING BLOOD OXYGEN LEVELS Final Rejection Oura Health Oy
17932434 SYSTEMS AND METHODS FOR ANESTHESIA DISPLAY Non-Final OA GE Precision Healthcare LLC
17504483 SELF-COMPENSATED FUNCTIONAL PHOTOACOUSTIC MICROSCOPY Non-Final OA CITY UNIVERSITY OF HONG KONG
18237567 PROVISION OF SESSIONS WITH INDIVIDUALLY TARGETED VISUAL STIMULI TOALLEVIATE CHRONIC PAIN IN USERS Non-Final OA Click Therapeutics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month